Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma PCSK9 levels in children and adolescents: evidence from an Italian outpatient paediatric clinic cohort at cardio-metabolic risk.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023
Same author

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2021
Same author

Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.

European review for medical and pharmacological sciences·2020
Same journal

Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative Review.

Reviews on recent clinical trials·2026
Same journal

The Gut Microbiota: A Functional Hub Linking Nutrition, Immunity, and Cardiovascular Health.

Reviews on recent clinical trials·2026
Same journal

Rupture of Renal Pelvis: A Case Report and Literature Review of a Rare Complication of Ureteral Lithiasis.

Reviews on recent clinical trials·2026
Same journal

Comparison between Tightrope and Hook Plate Techniques in the Treatment of Acromioclavicular Joint Dislocations: A Systematic Review and Meta-Analysis.

Reviews on recent clinical trials·2026
Same journal

Cerebral Air Embolism after Small-bore Chest Tube Insertion in a Patient with Hydropneumothorax: A Case Report.

Reviews on recent clinical trials·2026
Same journal

Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions.

Reviews on recent clinical trials·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

Methodological problems in RCTs on IBD.

M Cottone1, V Criscuoli, I Modesto

  • 1Dibimis (Biomedic Department of Internal and Specialistic Medicine), “V.Cervello” Hospital Palermo, Medicine Department "Ospedali Riuniti V.Sofia-Cervello" Hospital, Palermo, Italy.

Reviews on Recent Clinical Trials
|October 25, 2012
PubMed
Summary
This summary is machine-generated.

Randomized controlled trials (RCTs) are crucial for evidence-based inflammatory bowel disease (IBD) medicine. Improving RCT design, subject selection, and outcome measurement is vital for advancing IBD research.

More Related Videos

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Related Experiment Videos

Last Updated: May 17, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Trial Methodology
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine in inflammatory bowel disease (IBD).
  • Significant methodological challenges exist in conducting high-quality IBD RCTs.
  • These challenges impact the reliability and generalizability of research findings.

Purpose of the Study:

  • To identify and discuss key methodological issues in designing and conducting RCTs for IBD.
  • To emphasize the importance of efficient trial design and execution.
  • To provide recommendations for improving the IBD research process.

Main Methods:

  • Review and critical analysis of common methodological problems in IBD RCTs.
  • Discussion of factors influencing trial validity, including population variability, disease activity indices, outcome definition, environmental factors (e.g., smoking), placebo remission rates, and statistical analysis.
  • Synthesis of best practices for trial design and execution.

Main Results:

  • Heterogeneity in patient populations and disease activity indices complicates standardization.
  • Environmental risk factors like smoking can confound randomization and outcomes.
  • Variability in placebo remission rates and statistical methods affects result interpretation.
  • Lack of precise outcome measurement and careful subject selection hinders progress.

Conclusions:

  • Efficiently designed and well-executed RCTs are essential for advancing IBD research.
  • Standardization of disease activity indices and precise outcome measurement are critical.
  • Careful subject selection and consideration of environmental factors are necessary for robust trial results.
  • Addressing these methodological issues will enhance the quality and impact of IBD clinical trials.